Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 119
Filter
Add more filters










Publication year range
1.
Osteoarthritis Cartilage ; 24(2): 374-81, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26417696

ABSTRACT

OBJECTIVE: We investigated tissue turnover in healthy and osteoarthritic cartilage. We challenge long held views that osteoarthritis (OA) is dominated by a similar turnover process in all joints and present evidence that hip and knee cartilage respond very differently to OA. METHODS: d- and l-Aspartate (Asp) were quantified for whole cartilage, collagen and non-collagenous components of cartilage obtained at the time of joint replacement. We computed the Asp racemization ratio (Asp-RR = d/d + l Asp), reflecting the proportion of old to total protein, for each component. RESULTS: Compared with hip OA, knee OA collagen fibrils (P < 0.0001), collagen (P = 0.007), and non-collagenous proteins (P = 0.0003) had significantly lower age-adjusted mean Asp-RRs consistent with elevated protein synthesis in knee OA. Knee OA collagen had a mean hydroxyproline/proline (H/P) ratio of 1.2 consistent with the presence of type III collagen whereas hip OA collagen had a mean H/P ratio of 0.99 consistent with type II collagen. Based on Asp-RR, the relative age was significantly different in knee and hip OA (P < 0.0005); on average OA knees were estimated to be 30 yrs 'younger', and OA hips 10 yrs 'older' than non-OA. CONCLUSIONS: The metabolic response to OA was strikingly different by joint site. Knee OA cartilage evinced an anabolic response that appeared to be absent in hip OA cartilage. These results challenge the long held view that OA cartilage is capable of only minimal repair and that collagen loss is irreversible.


Subject(s)
Aspartic Acid/metabolism , Cartilage, Articular/metabolism , D-Aspartic Acid/metabolism , Osteoarthritis, Hip/metabolism , Osteoarthritis, Knee/metabolism , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Case-Control Studies , Collagen/metabolism , Collagen Type II/metabolism , Collagen Type III/metabolism , Female , Humans , Hydroxyproline/metabolism , Male , Middle Aged , Proline/metabolism , Young Adult
2.
Ann Rheum Dis ; 68(6): 983-90, 2009 Jun.
Article in English | MEDLINE | ID: mdl-18628282

ABSTRACT

OBJECTIVE: Thymic function declines exponentially with age. Impaired thymic function has been associated with autoimmune disease in adults but has never been formally assessed in childhood autoimmunity. Therefore, thymic function in children with the autoimmune disease juvenile idiopathic arthritis (JIA) was determined. METHODS: Thymic function was measured in 70 children and young adults with JIA (age range 2.1-30.8 (median 10.4)) and 110 healthy age-matched controls using four independent assays. T cell receptor excision circles (WBLogTREC/ml) and the proportion of CD4(+) CD45RA(+)CD31(+) T cells (representing recent thymic emigrants; %RTEs) were quantified and intrathymic proliferation measured by calculating the alphaTREC/SigmabetaTREC ratio. Lastly, regulatory T cells (T(Reg)) of thymic origin (CD4(+)FOXP3(+)) were quantified in peripheral blood to assess the ability of the thymus in JIA to generate this T cell subset. RESULTS: Thymic function was equivalent by all four parameters in JIA when compared with the control population. Furthermore, there was no consistent effect of JIA subtype on thymic function, although intrathymic proliferation was higher in the small rheumatoid factor (RF)(+) polyarticular group. There were no significant effects of disease-modifying antirheumatic drugs (DMARDs) or oral corticosteroids on thymic function, although those with the worst prognostic ILAR (International League of Associations for Rheumatology) subtypes were also those most likely to be on a DMARD. CONCLUSIONS: It is demonstrated that children and young adults with JIA, unlike adults with autoimmune diseases, have thymic function that is comparable with that of healthy controls. The varied pathologies represented by the term "JIA" suggest this observation may not be disease specific and raises interesting questions about the aetiology of thymic impairment in adult autoimmunity.


Subject(s)
Aging/physiology , Arthritis, Juvenile/immunology , T-Lymphocyte Subsets/immunology , Thymus Gland/physiology , Adolescent , Adult , Analysis of Variance , Antirheumatic Agents/therapeutic use , Arthritis, Juvenile/drug therapy , Biomarkers/analysis , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/immunology , Case-Control Studies , Cell Proliferation , Child , Child, Preschool , Female , Forkhead Transcription Factors/analysis , Glucocorticoids/therapeutic use , Humans , Male , Receptors, Antigen, T-Cell/genetics , Sex Factors , T-Lymphocytes, Regulatory/immunology , Young Adult
3.
J Periodontal Res ; 42(6): 580-8, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17956473

ABSTRACT

BACKGROUND AND OBJECTIVE: Cyclosporin-induced gingival overgrowth arises from an alteration in collagen homeostasis and is enhanced by inflammatory changes in the gingival tissues. The aim of this study was to investigate the interaction among interleukin-1, oncostatin M, cyclosporin and nifedipine in promoting the up-regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinase by gingival fibroblasts. MATERIAL AND METHODS: Fibroblast cultures (n = 5) were obtained from healthy controls and from patients with cyclosporin-induced gingival overgrowth, and cells were harvested between the fourth and ninth passages. Cells were stimulated with interleukin-1 and oncostatin M, alone or in combination, and with different concentrations of cyclosporin (0-2000 ng/mL) and nifedipine (0-200 ng/mL). MMP-1 and tissue inhibitor of metalloproteinase-1 production was determined using an enzyme-linked immunosorbent assay technique. A CyQuant cell proliferation assay was used to determine the DNA concentration in the sample. RESULTS: Fibroblasts obtained from patients with cyclosporin-induced gingival overgrowth produced significantly lower levels of MMP-1 than control fibroblasts (p < 0.001); tissue inhibitor of metalloproteinase-1 levels were significantly lower (p < 0.05), and the ratio of MMP-1 to tissue inhibitor of metalloproteinase-1 was reduced, in the conditioned medium of patients with cyclosporin-induced gingival overgrowth compared with controls. Interleukin-1 and oncostatin M produced a significant increase in the up-regulation of MMP-1, which was reversed when cyclosporin and nifedipine were added to the cell cultures (p < 0.05). CONCLUSION: Pro-inflammatory cytokines significantly up-regulate MMP-1 in cultured gingival fibroblasts. Up-regulation is attenuated by both cyclosporin and nifedipine. The interaction may account for the synergism between inflammation and cyclosporin-induced gingival overgrowth.


Subject(s)
Gingiva/metabolism , Gingival Overgrowth/metabolism , Matrix Metalloproteinase 1/biosynthesis , Tissue Inhibitor of Metalloproteinase-1/biosynthesis , Calcium Channel Blockers/pharmacology , Case-Control Studies , Cells, Cultured , Cyclosporine/adverse effects , Cyclosporine/pharmacology , Down-Regulation , Fibroblasts/metabolism , Gingiva/cytology , Gingival Overgrowth/chemically induced , Humans , Immunosuppressive Agents/adverse effects , Interleukin-1/physiology , Nifedipine/pharmacology , Oncostatin M/physiology
4.
Rheumatology (Oxford) ; 45(9): 1101-9, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16567360

ABSTRACT

OBJECTIVES: To develop a proteomics approach to study changes in the secreted protein levels of primary human chondrocytes after stimulation by the pro-inflammatory cytokines interleukin-1 and oncostatin M. METHODS: Using both the primary human articular and bovine nasal chondrocyte-conditioned mediums, methods were investigated to enable the separation of proteins by two-dimensional (2D) gel electrophoresis. Differentially regulated proteins were identified using tandem electrospray mass spectrometery. RESULTS: We discovered that proteoglycans and glycosylaminoglycans (GAGs) secreted by chondrocytes significantly interfered with 2D gel focusing. Several different methods for GAG removal were attempted including enzymic digestion, cetyl pyridinium chloride precipitation and anion exchange in high salt. The anion exchange proved to be the most effective. Even from these initial gels, we were able to identify eight proteins produced by human chondrocytes: matrix metalloproteinase (MMP)-1, MMP-3, YKL40, cyclophilin A, beta2-microglobulin, transthyretin, S100A11, peroxidine 1 and cofilin. MMP-1, MMP-3, YKL40 and cyclophilin A were all identified as processed, smaller peptide fragments. CONCLUSIONS: We were able to develop a novel sample preparation protocol to allow the reproducible sample preparation of secreted proteins from human chondrocytes. From the initial data, we were able to show that at least some of the proteins produced were cleaved to smaller fragments as a result of proteolysis. Therefore, this technique provides valuable information about protein processing which gene-based arrays do not.


Subject(s)
Chondrocytes/metabolism , Cytokines/pharmacology , Interleukin-1/pharmacology , Aged , Aged, 80 and over , Biomarkers/analysis , Cells, Cultured , Chondrocytes/immunology , Chromatography, Ion Exchange/methods , Cyclophilin A/analysis , Electrophoresis, Gel, Two-Dimensional/methods , Female , Humans , Male , Matrix Metalloproteinase 1/analysis , Matrix Metalloproteinase 3/analysis , Molecular Weight , Oncostatin M , Peptide Mapping/methods , Peroxidases/analysis , Peroxiredoxins , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Stimulation, Chemical
5.
Apoptosis ; 10(3): 493-8, 2005 May.
Article in English | MEDLINE | ID: mdl-15909111

ABSTRACT

Fenretinide induces apoptosis in SH-SY5Y neuroblastoma cells via a signaling pathway involving the production of reactive oxygen species (ROS), 12-lipoxygenase activity and the induction of the GADD153 transcription factor. NF-kappa B is a key element of many cell signaling pathways and adopts a pro- or anti-apoptotic role in different cell types. Studies have suggested that NF-kappa B may play a pro-apoptotic role in SH-SY5Y cells, and in other cell types NF-kappa B activation may be linked to lipoxygenase activity. The aim of this study was to test the hypothesis that NF-kappa B activity mediates fenretinide-induced apoptosis in SH-SY5Y neuroblastoma cells. Using a dominant-negative construct for Ikappa Balpha stably transfected into SH-SY5Y cells, we show that apoptosis, but not the induction of ROS, in response to fenretinide was blocked by abrogation of NF-kappa B activity. In parental SH-SY5Y cells, fenretinide induced NF-kappa B activity and Ikappa Balpha phosphorylation. These results suggest that NF-kappa B activity links fenretinide-induced ROS to the induction of apoptosis in SH-SH5Y cells, and may be a target for the future development of drugs for neuroblastoma therapy.


Subject(s)
Apoptosis/drug effects , Fenretinide/pharmacology , NF-kappa B/physiology , Flow Cytometry , Humans , I-kappa B Proteins/biosynthesis , NF-KappaB Inhibitor alpha , NF-kappa B/antagonists & inhibitors , Neuroblastoma , Phosphorylation , Reactive Oxygen Species/metabolism , Transfection , Tumor Cells, Cultured
6.
Int J Clin Pract ; 56(3): 227-8, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12018834

ABSTRACT

Pethidine is the most commonly used opioid in hospitals in the UK, but it lacks potency, has a short duration of action and a narrow therapeutic index. These points are illustrated by a case history of a patient prescribed pethidine for chronic abdominal pain. Misplaced fears of the side-effects of morphine result in its underuse in the management of chronic pain with consequential restriction of patients' functional ability.


Subject(s)
Abdominal Pain/drug therapy , Analgesics, Opioid , Meperidine , Abdominal Pain/etiology , Adult , Analgesics, Opioid/therapeutic use , Chronic Disease , Contraindications , Cystic Fibrosis/complications , Humans , Male , Morphine/therapeutic use
7.
Arthritis Rheum ; 44(10): 2296-310, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11665970

ABSTRACT

OBJECTIVE: To investigate the mechanism of interleukin-1alpha (IL-1alpha) and oncostatin M (OSM) synergistic regulation of matrix metalloproteinase 1 (MMP-1) in human chondrocytes. METHODS: Using an immortalized human chondrocyte cell line (T/C28a4), we investigated regulation of the MMP-1 gene. Northern blotting and flow cytometric analysis were used to assess changes in receptor, MMP-1, and c-fos expression. Transient transfections using MMP-1 promoter/luciferase constructs, electrophoretic mobility shift assay, and site-directed mutagenesis were used to investigate MMP-1 promoter activation. RESULTS: We found no alteration in the expression of receptors used by these cytokines after stimulation with IL-1alpha/OSM. Using MMP-1 promoter/luciferase reporter constructs, we found that the proximal (-517/+63) region of the MMP-1 promoter was sufficient to support a synergistic activation. A role for activated signal transducers and activators of transcription (STAT-3) was demonstrated, although no binding of STAT-3 to the MMP-1 promoter was found. However, constitutive binding of activator protein 1 (AP-1) was detected, and changes in c-fos expression could modulate promoter activity. CONCLUSION: Since no changes in receptor expression were observed, receptor modulation cannot account for the IL-1alpha/OSM synergy observed. Instead, the interplay of various intracellular signaling pathways is a more likely explanation. STAT activation is required, but STAT proteins do not interact directly with the MMP-1 promoter. We propose that activated STATs stimulate c-fos expression, and changes in expression of the AP-1 components regulate MMP-1 expression. We highlight a new mechanism for MMP-1 regulation in human chondrocytes that could provide potential new therapeutic targets.


Subject(s)
Chondrocytes/physiology , Interleukin-1/pharmacology , Matrix Metalloproteinase 1/physiology , Peptides/pharmacology , Cell Line, Transformed , DNA-Binding Proteins/physiology , Drug Synergism , Humans , Oncostatin M , Proto-Oncogene Proteins c-fos/physiology , STAT3 Transcription Factor , Signal Transduction/drug effects , Trans-Activators/physiology , Transcription Factor AP-1/physiology
8.
Chest ; 120(2): 384-9, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11502633

ABSTRACT

BACKGROUND: Memory oximeters enable diagnostic studies for sleep apnea hypopnea syndrome (SAHS) to be performed in the home. However, memory capabilities may be limited. STUDY OBJECTIVES: To compare a pulse oximeter used at home with an 8-h memory, storing data every 12 s, and in the laboratory, with on-line recording every 2 s. DESIGN: Prospective cohort study. SETTING: Patients' homes and a sleep laboratory. PATIENTS: One hundred patients with suspected SAHS. MEASUREMENTS: Home oximetry and a laboratory full polysomnography. The number of >/= 4% dips in pulse oximetric saturation (SpO(2)) was calculated for each study. Daytime sleepiness was assessed by the Epworth Sleepiness Scale (ESS) score. RESULTS: The mean dips per hour were 5.3/h (range, 0 to 53/h) for home studies and 13.4/h (range, 0 to 106/h) for laboratory studies; the relationship between home and laboratory studies was as follows: home = (0.4 x laboratory) - 0.01 +/- 11.2; r(2) = 0.64. Mean difference was 8.4/h (- 2.5 to + 77.9/h), which correlated with the mean of the measurements. At a cutoff point of 10/h, 52 studies were both negative and 13 studies were both positive. Nineteen home studies were false-negatives. Sensitivity was 0.41, and specificity was 1.0. In these 19 studies, 7 patients had an ESS score > 10 and 4 patients had an ESS score > 14. To confirm that differences were due to different sampling rates, 16 additional patients had on-line data and stored data collected simultaneously in the laboratory. Mean dips per hour were 3.2/h (range, 0.1 to 18.3/h) for the stored data and 8.34/h (0.2 to 22.8/h) for on-line data; the relationship being stored was as follows: 0.5 on-line - 1.17 +/- 2.6; r(2) = 0.69. Mean difference was 5.2/h (0.04 to 15.4 h), which correlated with the mean of the measurements. CONCLUSION: Home studies using a memory storage pulse oximeter may underestimate the number of hypoxic dips, probably due to sampling rates. Clinically significant hypoxic SAHS may therefore be missed.


Subject(s)
Oximetry , Sleep Apnea Syndromes/diagnosis , Cohort Studies , Equipment Design , Female , Home Nursing , Humans , Information Storage and Retrieval , Male , Middle Aged , Prospective Studies , Sensitivity and Specificity
9.
Mol Cell Endocrinol ; 181(1-2): 57-67, 2001 Jul 05.
Article in English | MEDLINE | ID: mdl-11476941

ABSTRACT

Reporter gene expression directed by a 1542-base pair (bp) fragment of the Kap promoter is specific to the proximal tubules of the kidney and androgen-regulated. In the present study, the characteristics of the androgen response from the 1542-bp promoter were examined in vivo. The estrogen response in the kidney and uterus was also examined. The reporter gene expression was assayed in lines of transgenic mice generated from a truncated promoter construct in which the L1 repeat, present at the distal portion of the 1542-bp, had been deleted. The pattern of androgen response of the reporter gene is similar to that of the endogenous Kap. Reporter gene expression in the 1542-bp promoter does not respond to estrogen in the kidney, while perinatal expression in the uterus does occur. Truncation of the L1 results in loss of reporter gene expression. We conclude that L1 sequences present near the Kap promoter have a regulatory function.


Subject(s)
Gene Expression Regulation , Long Interspersed Nucleotide Elements/genetics , Promoter Regions, Genetic/genetics , Proteins/genetics , Angiotensinogen/genetics , Animals , Autoradiography , Castration , Dose-Response Relationship, Drug , Estradiol/pharmacology , Female , Flutamide/pharmacology , Genes, Reporter/genetics , Humans , Kidney/drug effects , Kidney/metabolism , Male , Mice , Mice, Transgenic , Mutation/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Testosterone/pharmacology , Uterus/drug effects , Uterus/metabolism
10.
Novartis Found Symp ; 234: 205-18; discussion 218-28, 2001.
Article in English | MEDLINE | ID: mdl-11199097

ABSTRACT

The matrix metalloproteinases (MMPs) are a unique family of metalloenzymes that, once activated, can destroy connective tissue. The active enzymes are all inhibited by tissue inhibitors of metalloproteinases (TIMPs). The relative amounts of active MMPs and TIMPs are important in determining whether tissues are broken down in disease. Although elastase is often regarded as the target enzyme in chronic obstructive pulmonary disease (COPD), both the neutrophils and macrophages in the lung contain metalloproteinases and both collagen and elastin are degraded in disease. Transgenic studies have shown that when MMP1 is over-expressed, pulmonary emphysema develops in mice, while MMP12 knockout mice do not develop pulmonary emphysema when exposed to cigarette smoke. New drugs that can specifically block active MMPs are now available. These potent inhibitors are effective in vitro and prevent the destruction of tissue in animal models. Future patient trials will test the effectiveness of these compounds in preventing tissue destruction.


Subject(s)
Lung Diseases, Obstructive/drug therapy , Matrix Metalloproteinases/immunology , Tissue Inhibitor of Metalloproteinases/immunology , Animals , Humans , Lung Diseases/enzymology , Lung Diseases, Obstructive/enzymology , Matrix Metalloproteinases/metabolism , Matrix Metalloproteinases/therapeutic use , Tissue Inhibitor of Metalloproteinases/metabolism
11.
Ann Rheum Dis ; 60(2): 158-65, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11156550

ABSTRACT

OBJECTIVE: To determine if a new inhibitor, esculetin (EST), can block resorption of cartilage. METHODS: Interleukin 1alpha (IL1alpha, 0.04-5 ng/ml) and oncostatin M (OSM, 0.4-50 ng/ml) were used to stimulate the release of proteoglycan and collagen from bovine nasal cartilage and human articular cartilage in explant culture. Proteoglycan and collagen loss were assessed by dimethylmethylene blue and hydroxyproline assays, respectively. Collagenase levels were measured by assay of bioactivity and by enzyme linked immunosorbent assay (ELISA). The effects of EST on the expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in the transformed human chondrocyte cell line T/C28a4 were assessed by northern blot analysis. TIMP-1 protein levels were assayed by ELISA. The effect of EST on the MMP-1 promoter was assessed using a promoter-luciferase construct in transient transfection studies. RESULTS: EST inhibited proteoglycan and collagen resorption in a dose dependent manner with significant decreases seen at 66 microM and 100 microM EST, respectively. Collagenolytic activity was significantly decreased in bovine nasal cartilage cultures. In human articular cartilage, EST also inhibited IL1alpha + OSM stimulated resorption and decreased MMP-1 levels. TIMP-1 levels were not altered compared with controls. In T/C28a4 chondrocytes the IL1alpha + OSM induced expression of MMP-1, MMP-3, and MMP-13 mRNA was reduced to control levels by 250 microM EST. TIMP-1 mRNA levels were unaffected by EST treatment. All cytokine stimulation of an MMP-1 luciferase-promoter construct was lost in the presence of the inhibitor. CONCLUSION: EST inhibits degradation of bovine nasal cartilage and human articular cartilage stimulated to resorb with IL1alpha + OSM.


Subject(s)
Biological Products/pharmacology , Chondrocytes/drug effects , Interleukin-1/antagonists & inhibitors , Umbelliferones/pharmacology , Animals , Blotting, Northern , Cattle , Cells, Cultured , Chondrocytes/enzymology , Collagen/physiology , Dose-Response Relationship, Drug , Enzyme-Linked Immunosorbent Assay , Humans , Hydroxyproline , Matrix Metalloproteinases/drug effects , Methylene Blue , Proteoglycans/physiology , Tissue Inhibitor of Metalloproteinase-1/drug effects
12.
Endocrinology ; 141(5): 1608-17, 2000 May.
Article in English | MEDLINE | ID: mdl-10803568

ABSTRACT

Dihydrotestosterone (DHT) is the most potent naturally occurring androgen, and its production in the testis may have important consequences in developmental and reproductive processes. In the rat testis, three factors can contribute to intracellular DHT levels: 1) synthesis of DHT from T by 5alpha-reductase, 2) conversion of DHT to 5alpha-androstane-3alpha, 17beta-diol (3alpha-DIOL) by the reductive activity of 3alpha-hydroxysteroid dehydrogenase (3alpha-HSD), and 3) conversion of 3alpha-DIOL by an oxidative 3alpha-HSD activity. While the type I 3alpha-HSD enzyme (3alpha-HSD1 or AKR1C9) is an oxidoreductase in vitro and could theoretically be responsible for factors 2 and 3, we have shown previously that rat Leydig cells have two 3alpha-HSD activities: a cytosolic NADP(H)- dependent activity, characteristic of 3alpha-HSD1, and a microsomal NAD(H)-dependent activity. The two activities were separable by both developmental and biochemical criteria, but the identity of the second enzyme was unknown. To identify the microsomal NAD(H)-dependent 3alpha-HSD in rat Leydig cells, degenerate primers were used to amplify a number of short-chain alcohol dehydrogenases. Sequence analysis of cloned PCR products identified retinol dehydrogenase type II (RoDH2) as the prevalent species in purified Leydig cells. RoDH2 cDNA was subcloned into expression vectors and transiently transfected into CHOP and COS-1 cells. Its properties were compared with transiently transfected 3alpha-HSD1. When measured in intact CHOP and COS-1 cells, RoDH2 cDNA produced a protein that catalyzed the conversions of 3alpha-DIOL to DHT and androsterone to androstanedione, but not the reverse reactions. Therefore, the 3alpha-HSD activity of RoDH2 was exclusively oxidative. In contrast, type I 3alpha-HSD cDNA produced a protein that was exclusively a 3alpha-HSD reductase. In cell homogenates and subcellular fractions, RoDH2 catalyzed both 3alpha-HSD oxidation and reduction reactions that were NAD(H) dependent, and the enzyme activities were located in the microsomes. Type I 3alpha-HSD also catalyzed both oxidation and reduction, but was located in the cytosol and was NADP(H) dependent. We conclude that type I 3alpha-HSD and RoDH2 have distinct 3alpha-HSD activities with opposing catalytic directions, thereby controlling the rates of DHT production by Leydig cells.


Subject(s)
3-Hydroxysteroid Dehydrogenases/metabolism , Alcohol Oxidoreductases/metabolism , Leydig Cells/enzymology , Alcohol Oxidoreductases/genetics , Animals , COS Cells , Catalysis , Cells, Cultured , Cytochrome P450 Family 2 , DNA Primers/metabolism , Humans , Isoenzymes/genetics , Isoenzymes/metabolism , Male , Oxidation-Reduction , Rats , Transfection
13.
Eur Respir J ; 14(1): 239-41, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10489859

ABSTRACT

This report describes three cases who underwent uvulopalatopharyngoplasty for severe snoring and who subsequently developed progressive excessive daytime sleepiness. All three cases were shown to have sleep fragmentation as a result of non-apnoeic episodic upper airway narrowing. These cases raise the possibility that increased upper airway resistance during sleep may be exacerbated or even caused by uvulopalatopharyngoplasty. Ideally, sleep-disordered breathing should be carefully excluded before this surgery is offered as treatment for severe snoring.


Subject(s)
Disorders of Excessive Somnolence/etiology , Otorhinolaryngologic Surgical Procedures/adverse effects , Pharynx/surgery , Plastic Surgery Procedures/adverse effects , Snoring/surgery , Uvula/surgery , Adult , Cephalometry , Humans , Male , Middle Aged , Radiography , Snoring/diagnostic imaging
15.
Biol Reprod ; 60(4): 855-60, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10084958

ABSTRACT

The enzyme 3alpha-hydroxysteroid dehydrogenase (3alpha-HSD) has an important role in androgen metabolism, catalyzing the interconversion of dihydrotestosterone (DHT) and 5alpha-androstane-3alpha,17beta-diol (3alpha-DIOL). The net direction of this interconversion will affect the amount of biologically active ligand available for androgen receptor binding. We hypothesize that in Leydig cells, differential expression of 3alpha-HSD enzymes favoring one of the two directions is a mechanism by which DHT levels are controlled. In order to characterize 3alpha-HSD in rat Leydig cells, the following properties were analyzed: rates of oxidation (3alpha-DIOL to DHT) and reduction (DHT to 3alpha-DIOL) and preference for the cofactors NADP(H) and NAD(H) (i.e., the oxidized and reduced forms of both pyridine nucleotides) in Leydig cells isolated on Days 21, 35, and 90 postpartum. Levels of 3alpha-HSD protein were measured by immunoblotting using an antibody directed against the liver type of the enzyme. Levels of 3alpha-HSD protein and rates of reduction were highest on Day 21 and lowest on Day 90. The opposite was true for the rate of 3alpha-HSD oxidation, which was barely detectable on Day 21 and highest on Day 90 (59.08 +/- 6.35 pmol/min per 10(6) cells, mean +/- SE). Therefore, the level of 3alpha-HSD protein detectable by liver enzyme was consistent with reduction but not with oxidation. There was a clear partitioning of NADP(H)-dependent activity into the cytosolic fraction of Leydig cells, whereas on Days 35 and 90, Leydig cells also contained a microsomal NAD(H)-activated 3alpha-HSD. We conclude that 1) the cytosolic 3alpha-HSD in Leydig cells on Day 21 behaves as a unidirectional NADPH-dependent reductase; 2) by Day 35, a microsomal NAD(H)-dependent enzyme activity is present and may account for predominance of 3alpha-HSD oxidation over reduction and the resultant high capacity of Leydig cells on Day 90 to synthesize DHT from 3alpha-DIOL.


Subject(s)
3-Hydroxysteroid Dehydrogenases/metabolism , Leydig Cells/enzymology , Sexual Maturation , 3-Hydroxysteroid Dehydrogenases/analysis , 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) , Androstane-3,17-diol/metabolism , Animals , Cytosol/enzymology , Dihydrotestosterone/metabolism , Female , Immunoblotting , Leydig Cells/ultrastructure , Male , Microsomes/enzymology , NAD/pharmacology , NADP/pharmacology , Oxidation-Reduction , Rats , Rats, Sprague-Dawley
16.
Gene ; 228(1-2): 253-60, 1999 Mar 04.
Article in English | MEDLINE | ID: mdl-10072778

ABSTRACT

Follicle-stimulating hormone (FSH) is one of the key regulators of gonadal function in mammals. Recombinant DNA expression of this hormone has proved to be a difficult task as expression levels are invariably low, irrespective of the expression system employed. In the present study, we have attempted to identify reasons for this low expression using bacterial expression vectors, and we report here the identification of a theoretically predicted hairpin structure in the mRNA corresponding to the N-terminal portion of the mature coding portion of bFSHbeta cDNA that is responsible for attenuating its expression in E. coli. When full-length FSHbeta was expressed using the bacterial expression vector, a very low expression was obtained. However, when fragments of FSHbeta with N-terminal deletions (amino acids 24-110 and 13-110) were expressed using the same expression strategy, a 30- to 40-fold higher expression was observed. This low expression of FSHbeta could be attributed to a hairpin structure present in the first 12 codons of mature FSHbeta mRNA. Disruption of this structure without changing the amino acid sequence resulted in a higher level of expression of FSHbeta. The predicted hairpin structure, though away from the transcriptional and translational start site, was able to downregulate the expression of FSHbeta probably by impeding the movement of ribosomes.


Subject(s)
Escherichia coli/genetics , Follicle Stimulating Hormone/genetics , RNA, Messenger/genetics , Regulatory Sequences, Nucleic Acid , Animals , Cattle , Follicle Stimulating Hormone, beta Subunit , Gene Expression Regulation, Bacterial , Nucleic Acid Conformation , Plasmids/genetics , RNA, Messenger/chemistry , RNA, Messenger/metabolism , Recombinant Fusion Proteins/genetics
17.
Clin Exp Metastasis ; 17(7): 583-91, 1999.
Article in English | MEDLINE | ID: mdl-10845557

ABSTRACT

The adhesion of tumour cells to the hyaluronan (HA) pericellular coat of mesothelial cells is an important step in the peritoneal spread of ovarian cancer. Previously, we have shown that the cell surface molecule CD44 is involved in this process. Paradoxically, the degree of adhesion does not appear to be related to the amount of CD44 expressed. In order to explain this observation we have examined the in vitro adhesion to HA of four high CD44-expressing ovarian cancer lines in relation to their CD44 spliced variant content and the CD44 glycosylation. Adhesion was measured in multiwell plates coated with different concentrations of HA in order to determine both the avidity and the maximum adhesion. Two lines had high adhesion and two lines had low adhesion. The avidity for HA was different for each line, but in all cases this could be totally blocked by treatment with an anti-CD44 antibody. The standard form of CD44 was the major species detected by RT/PCR in all lines and spliced variants were present in low amounts. Neuraminidase treatment increased the adhesion of the 'low-adhesion' lines at all HA coating concentrations; but only substantially increased the adhesion of the 'high-adhesion' lines at the lower HA coating concentrations. Tunicamycin treatment decreased the adhesion of the 'high-adhesion lines' at all HA coating concentrations and only substantially decreased the adhesion of one of the 'low-adhesion' lines when the plates were coated with a low concentration of HA. The adhesion of the remaining 'low-adhesion' line was slightly increased after tunicamycin treatment. It is concluded that glycosylation and not spliced variant content of CD44 affects the adhesive properties of ovarian tumour cells. This conclusion may have important consequences for developing new therapies in ovarian cancer.


Subject(s)
Carcinoma, Endometrioid/pathology , Cell Adhesion Molecules/physiology , Cell Adhesion , Cystadenocarcinoma, Papillary/pathology , Hyaluronan Receptors/physiology , Hyaluronic Acid/physiology , Membrane Glycoproteins/physiology , Neoplasm Metastasis/physiopathology , Neoplasm Proteins/physiology , Ovarian Neoplasms/pathology , Protein Processing, Post-Translational , Carcinoma, Endometrioid/metabolism , Cell Adhesion Molecules/biosynthesis , Cystadenocarcinoma, Papillary/metabolism , Female , Glycosylation/drug effects , Humans , Hyaluronan Receptors/biosynthesis , Membrane Glycoproteins/biosynthesis , N-Acetylneuraminic Acid/chemistry , Neoplasm Proteins/biosynthesis , Neuraminidase/pharmacology , Ovarian Neoplasms/metabolism , Peritoneal Neoplasms/secondary , Protein Binding , Protein Processing, Post-Translational/drug effects , Tumor Cells, Cultured , Tunicamycin/pharmacology
18.
Physiol Genomics ; 1(1): 3-9, 1999 Jul 15.
Article in English | MEDLINE | ID: mdl-11015555

ABSTRACT

We tested the hypothesis that the tissue-specific intrarenal renin-angiotensin system (RAS) can participate in the regulation of blood pressure independently of its endocrine counterpart, by generating two transgenic models that differ in their tissue-specific expression of human angiotensinogen (AGT). Human AGT expression was driven by its endogenous promoter in the systemic model and by the kidney androgen-regulated protein promoter in the kidney-specific model. Using molecular, biochemical, and physiological measurements, we demonstrate that human AGT mRNA and protein are restricted to the kidney in the kidney-specific model. Plasma ANG II was elevated in the systemic model but not in the kidney-specific model. Nevertheless, blood pressure was markedly elevated in both the systemic and kidney-specific transgenic mice. Acute administration of the selective ANG II AT-1 receptor antagonist losartan lowered blood pressure in the systemic model but not in the kidney-specific model. These results provide evidence for the potential importance of the intrarenal RAS in blood pressure regulation by showing that expression of AGT specifically in the kidney leads to chronic hypertension independently of the endocrine RAS.


Subject(s)
Angiotensinogen/genetics , Gene Targeting , Hypertension/genetics , Renin-Angiotensin System/genetics , Angiotensin Receptor Antagonists , Angiotensinogen/metabolism , Animals , Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Blood Pressure/genetics , Disease Models, Animal , Humans , Hypertension/metabolism , Kidney/metabolism , Losartan/pharmacology , Mice , Mice, Transgenic , Organ Specificity/genetics , Promoter Regions, Genetic , RNA, Messenger/metabolism , Receptor, Angiotensin, Type 1 , Receptor, Angiotensin, Type 2 , Renin-Angiotensin System/drug effects
19.
J Steroid Biochem Mol Biol ; 71(5-6): 213-22, 1999 Dec 31.
Article in English | MEDLINE | ID: mdl-10704910

ABSTRACT

CNNT. There was a good correlation between bioactivity and binding affinity to AR for the 7alpha-substituted androgens compared to T. In contrast, relative to their binding affinity to AR, the androgenic potency of DHT and 19-NT was lower compared to T. The reason for the lower in vivo androgenic activity of 19-NT is attributable to its enzymatic conversion to 5alpha-reduced-19-NT in the prostate. In the case of DHT, the lower bioactivity could be attributed to its faster metabolic clearance rate relative to T. The correlation was further investigated in vitro by co-transfection of rat ARcDNA expression plasmid and a reporter plasmid encoding the chloramphenicol acetyl transferase (CAT) gene driven by an androgen inducible promoter into CV-1 cells. All the androgens led to a dose-dependent increase in the CAT activity. MENT was found to be the most potent followed by DHT, 19-NT, T, and CNNT. The specificity of the androgenic response was confirmed by its inhibition with hydroxyflutamide, an antiandrogen. Thus, there was a good correlation between binding affinity and in vitro bioactivity in the transient transfection assay for the androgens. This suggests that the in vivo bioactivity of androgens could be influenced not only by binding affinity to receptors but also by factors such as absorption, binding to serum proteins and metabolism. However, the high potency of MENT is primarily related to its higher affinity to AR.


Subject(s)
Androgens/pharmacology , Nandrolone/analogs & derivatives , Testosterone/analogs & derivatives , Androgen Antagonists/pharmacology , Androgens/metabolism , Animals , Binding, Competitive , Castration , Cell Line , Flutamide/analogs & derivatives , Flutamide/pharmacology , Genes, Reporter , Male , Nandrolone/metabolism , Nandrolone/pharmacology , Organ Size/drug effects , Prostate/drug effects , Rats , Rats, Sprague-Dawley , Receptors, Androgen/genetics , Receptors, Androgen/metabolism , Sex Hormone-Binding Globulin/metabolism , Structure-Activity Relationship , Testosterone Congeners/metabolism , Transfection
20.
Endocrinology ; 138(12): 5089-95, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9389487

ABSTRACT

Glucocorticoids directly regulate testosterone production in Leydig cells through a glucocorticoid receptor (GR)-mediated repression of the genes that encode testosterone biosynthetic enzymes. The extent of this action is determined by the numbers of GR within the Leydig cell, the intracellular concentration of glucocorticoid, and 11beta-hydroxysteroid dehydrogenase (11betaHSD) activities that interconvert corticosterone (in the rat) and its biologically inert derivative, 11-dehydrocorticosterone. As glucocorticoid levels remain stable during pubertal development, GR numbers and 11betaHSD activities are the primary determinants of glucocorticoid action. Therefore, in the present study, levels of GR and 11betaHSD messenger RNA (mRNA) and protein were measured in rat Leydig cells at three stages of pubertal differentiation: mesenchymal-like progenitors (PLC) on day 21, immature Leydig cells (ILC) that secrete 5alpha-reduced androgens on day 35, and adult Leydig cells (ALC) that are fully capable of testosterone biosynthesis on day 90. Numbers of GR, measured by [3H]dexamethasone binding, in purified cells were 6.34 +/- 0.27 (x 10(3) sites/cell; mean +/- SE) for PLC, 30.45 +/- 0.74 for ILC, and 32.54 +/- 0.84 for ALC. Although GR binding was lower in PLC, steady state levels for GR mRNA were equivalent at all three stages (P > 0.05). Oxidative and reductive activities of 11betaHSD were measured by assaying the conversion of radiolabeled substrates in incubations of intact Leydig cells. Both oxidative and reductive activities were barely detectable in PLC, intermediate in ILC, and highest in ALC. The ratio of the two activities favored reduction in PLC and ILC and oxidation in ALC (oxidation/reduction, 0.33 +/- 0.33 for PLC, 0.43 +/- 0.05 for ILC, and 2.12 +/- 0.9 for ALC, with a ratio of 1 indicating equivalent rates for both activities). The mRNA and protein levels of type I 11betaHSD in Leydig cells changed in parallel with 11betaHSD reductive activity, which increased gradually during the transition from PLC to ALC, compared with the sharp rise that was seen in oxidative activity. We conclude that Leydig cells at all developmental stages have GR and that their ability to respond to glucocorticoid diminishes as net 11betaHSD activity switches from reduction to oxidation. This provides a mechanism for the Leydig cell to regulate its intracellular concentration of corticosterone, thereby varying its response to this steroid during pubertal development.


Subject(s)
Aging/metabolism , Hydroxysteroid Dehydrogenases/metabolism , Leydig Cells/metabolism , Receptors, Glucocorticoid/metabolism , 11-beta-Hydroxysteroid Dehydrogenases , Animals , Binding Sites , Dexamethasone/metabolism , Glucocorticoids/metabolism , Male , Oxidation-Reduction , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Glucocorticoid/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...